DataMEDS AI is building a connected healthcare ecosystem that brings together technology, data and specialized healthcare companies to make care more accessible, efficient and connected.
Our portfolio spans pharmacy, telemedicine, laboratory services, health technology, distribution, wellness and patient support. Each company brings specialized expertise and operates independently, while contributing to a broader platform designed to connect patients, providers, pharmacies and healthcare partners across the continuum of care.
Its growing ecosystem connects pharmacy, distribution, patient services and technology to create a more efficient and connected healthcare experience.
“Our vision is to build a healthcare organization where every company, technology and partnership strengthens the next. By bringing together complementary capabilities under a shared strategy, we believe we can accelerate growth, expand our impact and build lasting value for our partners, our customers and our shareholders.”
A comprehensive suite of index solutions, including the Nasdaq-100, designed to meet the evolving needs of today’s investors
Unifying trading, risk, treasury, clearing and collateral on a single platform
Helping financial institutions stop fraud, money laundering and predicate crimes
Stay informed with our latest corporate materials and updates. Explore our Investor Presentation for an overview of our projects and strategy, review the Fact Sheet for key financial and operational highlights, and Subscribe to receive company news, reports, and investor updates directly to your inbox.
By bringing these capabilities together, we create stronger connections across the healthcare journey and new opportunities for the organizations and people we serve.
Connecting patients with easier access to medications, healthcare services.
Supporting providers with technology, data and healthcare services .
Empowering independent pharmacies with technology, prescription opportunities.
DataMEDS AI is building a scalable healthcare platform that combines technology, pharmacy, distribution, patient access and data-driven solutions. Through strategic acquisitions and partnerships, the company is expanding its capabilities and reach while connecting complementary businesses across the healthcare ecosystem.
For investors, the opportunity is straightforward: a growing portfolio of healthcare businesses supported by technology, AI and data, with multiple pathways for expansion and long-term value creation.
The global medication adherence market segment is growing and is quickly projected to reach $11.2 Billion by 2030.
We’re here to help you with any inquiries, project details, or investment opportunities. Whether you’re an investor, partner, or simply looking to learn more about our operations, our team is ready to assist you.
The intelligence layer. As this data strategy matures, DataMEDS AI is also exploring ways for patients to participate directly in the value their own health data helps create – turning information they already generate into value for them, not just the system around them.